Hims & Hers Health Inc（HIMS）價格預測HIMSHims & Hers Health Inc

Alphio's HIMS stock price prediction model matches the current Hims & Hers Health Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.80 (-0.15%). The 1-week path is $29.10 (+0.89%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Hims & Hers Health Inc is not a good buy right now due to significant risks overshadowing its potential. The current price is $28.84, and the stock has dropped 14.62% over the past five days, indicating negative momentum. Additionally, the RSI is at 40.773, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The company is facing serious legal challenges, including a lawsuit from the FTC and scrutiny from Visa, which could further impact its reputation and financial stability. The forward P/E ratio is high at 58.82, indicating that the stock is overvalued relative to its earnings potential, and the gross margin has decreased to 63.83%, reflecting declining profitability. The main risk is the ongoing FTC investigation, which could lead to further financial penalties and loss of customer trust, potentially driving the stock price lower.

Hims & Hers Health Inc (HIMS) last closed at $28.84, losing -8.91%. These facts feed the 1-day and 1-week HIMS price prediction above.